Table Of ContentSa
Clinica Chimica Acta 283 (1999) 205-206
Author index
Volume 283 (1999)
Abe, S., Gunji, H., Kunii, S., Kuraya, M., Fujita, Chalmers, J., see Brown, LR. 283, 119
T., Hiraiwa, K., Semen specific -y-glutamyltrans- Christensen, H., Carlson, E., Asberg, A., Schram,
ferase carries ABH antigens: a sandwich ELISA L., Berg, K.J., A simple and sensitive high-
for simultaneous semen detection and its ABO performance liquid chromatography assay of
blood typing 283, 183 diltiazem and main metabolites in renal trans-
Amr, K.S., see El-Awady, M.K. 283, | planted patients 283, 63
Andersson, A., see Hultberg, B. 283, 21
Andou, M., see Sumi, S. 283, 201 Dauzat, M., see Bertinchant, J.-P. 283, 43
Asanuma, K., Yagihashi, A., Uehara, N., Kida, T., de la Coussaye, J.-E., see Bertinchant, J.-P. 283,
Watanabe, N., Three point mutations of human 43
butyrylcholinesterase in a Japanese family and
the alterations of three-dimensional structure El-Awady, M.K., Ismail, S.M., El-Sagheer, M.,
283, 33 Sabour, Y.A., Amr, K.S., Zaki, E.A., Assay for
Asberg, A., see Christensen, H. 283, 63 hepatitis C virus in peripheral blood mononu-
clear cells enhances sensitivity of diagnosis and
Bali, J.-P., see Bertinchant, J.-P. 283, 43 monitoring of HCV-associated hepatitis 283, |
Benedik, M., see Séanéar, J. 283, 139 El-Sagheer, M., see El-Awady, M.K. 283, 1
Berg, K.J., see Christensen, H. 283, 63 Evans, J.E., see Hagen, T. 283, 77
Bertinchant, J.-P., Polge, A., Robert, E., Sabbah,
N., Fabbro-Peray, P., Poirey, S., Laprade, M., Fabbro-Peray, P., see Bertinchant, J.-P. 283, 43
Pau, B., Juan, J.-M., Bali, J.-P., de la Coussaye, Favre, S., see Sabot, J.-F. 283, 151
J.-E., Dauzat, M., Time-course of cardiac Fujita, M., see Ikemoto, M. — 283, 171
troponin I release from isolated perfused rat Fujita, T., see Abe, S. 283, 183
hearts during hypoxia/reoxygenation and _ is-
chemia/reperfusion 283, 43 Gunji, H., see Abe, S. 283, 183
Bornet, C.-E., see Sabot, J.-F. 283, 151
Brown, E.R., see Brown, LR. 283, 119 Hagen, T., Korson, M.S., Sakamoto, M., Evans,
Brown, I.R., McBain, A.M., Chalmers, J., Camp- J.E.. A GC/MS/MS screening method for
bell, LW., Brown, E.R., Lewis, M.J., Sex differ- multiple organic acidemias from urine specimens
ence in the relationship of calcium and mag- 283, 77
nesium excretion to glycaemic control in type | Hamajima, N., see Sumi, S. 283, 201
diabetes mellitus 283, 119 Hasegawa, K., see Ikemoto, M. 283, 171
Bukovec, P., see Séanéar, J. 283, 139 Hashimoto, R., see Tanimukai, H. 283, 57
Hiraiwa, K., see Abe, S. 283, 183
Campbell, I.W., see Brown, LR. 283, 119 Hobbs, G.A., see Kaplan, LV. 283, 89
Carlson, E., see Christensen, H. 283, 63 Hultberg, B., Andersson, A., Isaksson, A., Thiol
PII: $009-8981(99)00068-6
206 Author index vol. 283 (1999)
and redox reactive agents exert different effects Sabot, J.-F.. Bornet, C.-E., Favre, S., Sabot-
on glutathione metabolism in HeLa cell cultures Gueriaux, S., The analysis of peculiar urinary
283, 21 (and other) calculi: an endless source of chal-
lenge 283, 151
Igarashi, S., see Takahata, K. 283, 129
Sabot-Gueriaux, S., see Sabot, J.-F. 283, 151
Ikemoto, M., Hasegawa, K., Kihara, Y., Iwakura, Sabour, Y.A., see El-Awady, M.K. 283, |
A., Komeda, M., Yamazato, A., Fujita, M., Sagnella, G.A., Miller, M.A., Khong, T.K., Mac-
Development of enzyme-linked immunosorbent Gregor, G.A., Platelet sodium/hydrogen ex-
assay for acidic fibroblast growth factor and its
changer activity in normotensives and hyperten-
clinical application 283, 171
sives 283, 105
Isaksson, A., see Hultberg, B. 283, 21
Sakamoto, M., see Hagen, T. 283, 77
Ismail, S.M., see El-Awady, M.K. 283, | Séanéar, J., Milaci¢, R., Benedik, M., Bukovec, P.,
Iwakura, A., see Ikemoto, M. 283, 171
Problems related to determination of trace ele-
Johnson, N.A., see Jortani, S.A. 283, 159 ments in spent continuous ambulatory peritoneal
Jortani, S.A., Pinar, A., Johnson, N.A., Valdes Jr., dialysis fluids by electrothermal atomic absorp-
tion spectrometry 283, 139
R., Validity of unbound digoxin measurements
Schram, L., see Christensen, H. 283, 63
by immunoassays in presence of antidote
(Digibind’) 283, 159 Schulze, A., Kohimueller, D., Mayatepek, E., Sen-
Juan, J.-M., see Bertinchant, J.-P. 283, 43 sitivity of electrospray-tandem mass _ spec-
trometry using the phenylalanine/tyrosine-ratio
Kamino, K., see Tanimukai, H. 283, 57 for differential diagnosis of hyperpheny!l-
Kaplan, LV., Hobbs, G.A., Levinson, S.S., Simpler alaninemia in neonates 283, 15
technique for measuring oxidative susceptibility Shinozaki, K., see Tanimukai, H. 283, 57
by heparin affinity column isolation of lipopro- Stickle, D.F., McNeil, S.E., Evaluation of use of
teins 283, 89 singleton measurements of C-peptide by RIA
Khong, T.K., see Sagnella,G.A. 283, 105 283, 195
Kida, T., see Asanuma, K. 283, 33 Sumi, S., Andou, M., Hamajima, N., Kidouchi, K.,
Kidouchi, K., see Sumi, S. 283, 201 Togari, H., Wada, Y., Uracil phosphoribosyl-
Kihara, Y., see Ikemoto, M. 283, 171 transferase activity in hereditary orotic aciduria
Kohimueller, D., see Schulze, A. 283, 15 283, 201
Komeda, M., see Ikemoto, M. 283, 171
Korson, M.S., see Hagen, T. 283, 77 Takahata, K., Igarashi, S., Spectrophotometric de-
Kudo, T., see Tanimukai, H. 283, 57 termination of trace amounts of hemoglobin
Kunii, S., see Abe, S. 283, 183 using the oxidative decomposition reaction of a
Kuraya, M., see Abe, S. 283, 183 copper(II)—phthalocyanine complex 283, 129
Takeda, M., see Tanimukai, H. 283, 57
Laprade, M., see Bertinchant, J.-P. 283, 43 Tanimukai, H., Tsujio, 1., Hashimoto, R., Kudo, T.,
Levinson, S.S., see Kaplan, LV. 283, 89 Kamino, K., Shinozaki, K., Takeda, M.,
Lewis, M.J., see Brown, LR. 283, 119 Presenilin-2 mutation and polymorphism in
Japanese Alzheimer disease patients 283, 57
MacGregor, G.A., see Sagnella,G.A. 283, 105
Togari, H., see Sumi, S. 283, 201
Mayatepek, E., see Schulze, A. 283, 15
Tsujio, L, see Tanimukai, H. 283, 57
McBain, A.M., see Brown, LR. 283, 119
McNeil, S.E., see Stickle, D.F. 283, 195
Milavig, R., see Séanéar, J. 283, 139 Uehara, N., see Asanuma, K. 283, 33
Miller, M.A., see Sagnella,G.A. 283, 105
Valdes Jr., R., see Jortani, S.A. 283, 159
Pau, B., see Bertinchant, J.-P. 283, 43
Pinar, A., see Jortani, S.A. 283, 159 Wada, Y., see Sumi, S. 283, 201
Poirey, S., see Bertinchant, J.-P. 283, 43 Watanabe, N., see Asanuma, K. 283, 33
Polge, A., see Bertinchant, J.-P. 283, 43
Yagihashi, A., see Asanuma, K. 283, 33
Robert, E., see Bertinchant, J.-P. 283, 43 Yamazato, A., see Ikemoto, M. 283, 171
Sabbah, N., see Bertinchant, J.-P. 283, 43 Zaki, E.A., see El-Awady, M.K. = 283, |
. a)!
ELSEVIER Clinica Chimica Acta 283 (1999) 207-209
Subject index
Volume 283 (1999)
ABH antigen carrier protein; Semen specific y- Copper; Spent CAPD fluid; Aluminium; Iron;
GTP; Monoclonal antibodies; Sandwich ELISA ETAAS 283, 139
283, 183
Copper(II)-phthalocyanine complex; Spectro-
Acid excretion; Hypertension; Sodium/hydrogen photometry; Hemoglobin; Oxidative decomposi-
exchanger; Platelets 283, 105 tion reaction 283, 129
aFGF; ELISA; Growth factor; Pericardial fluid; Coronary artery disease; aFGF; ELISA; Growth
Coronary artery disease 283, 171 factor; Pericardial fluid 283, 171
Aluminium; Spent CAPD fluid; Copper: Iron; Coronary artery disease; Arteriosclerosis; Fibrin-
ETAAS 283, 139
ogen; Antioxidants 283, 89
Alzheimer disease; Presenilin 2; RFLP 283, 57
Cysteine; Glutathione; Homocysteine; Human cell
lines; Oxidative agents; Redox status; Thiol-reac-
Antioxidants; Arteriosclerosis; Coronary artery
tive agents 283, 21
disease; Fibrinogen 283, 89
Diabetes mellitus: Calcium; Magnesium,
Arteriosclerosis; Coronary artery disease: Fibrino-
Glycaemic control 283, 119
gen; Antioxidants 283, 89
Digibind *; Digoxin; Fab fragments; Immunoassays
Artifact; Calculi; Factitious calculi; Infrared spec-
283, 159
trophotometry; Munchausen syndrome; Urinary
calculi 283, 151
Digoxin; Digibind”; Fab fragments; Immunoassays
Butyrylcholinesterase; Point mutation; Three-di- 283, 159
mensional structure and atypical gene 283, 33
Diltiazem; Metabolites; SPE; HPLC 283, 63
Calcium; Magnesium; Glycaemic control; Diabetes
mellitus 283, 119 Electrospray-tandem mass spectrometry; Hyper-
phenylalaninemia; Neonatal screening; Phenylal-
Calculi; Artifact; Factitious calculi; Infrared spec- anine; Tyrosine 283, 15
trophotometry; Munchausen syndrome; Urinary
calculi 283, 151 ELISA; aFGF; Growth factor; Pericardial fluid;
Coronary artery disease 283, 171
Cardiac troponin I; Hypoxia/reoxygenation; Im-
munoassay; Ischemia/reperfusion; Isolated per- ETAAS,; Spent CAPD fluid; Aluminium; Copper;
fused heart rat 283, 43 Iron 283, 139
PII: S009-8981(99)00069-8
208 Subject index vol. 283 (1999)
Fab fragments; Digoxin; Digibind”; Immuno- Infrared spectrophotometry; Artifact; Calculi;
assays 283, 159 Factitious calculi; Munchausen syndrome; Urin-
ary calculi 283, 151
Factitious calculi; Artifact; Calculi; Infrared spec-
trophotometry; Munchausen syndrome; Urinary Ion trap GC/MS; Gas chromatography /tandem
calculi 283, 151 mass spectrometry; Organic acidemias; Screen-
ing 283, 77
Fibrinogen; Arteriosclerosis; Coronary artery dis-
ease; Antioxidants 283, 89 Iron; Spent CAPD fluid; Aluminium; Copper;
ETAAS 283, 139
Gas _ chromatography/tandem mass _spec-
trometry; lon trap GC/MS; Organic acidemias; Ischemia/reperfusion; Cardiac troponin I; Hypo-
Screening 283, 77
xia/reoxygenation; Immunoassay; Isolated per-
fused heart rat 283, 43
Glutathione, Cysteine; Homocysteine; Human cell
lines; Oxidative agents; Redox status; Thiol-reac-
tive agents 283, 21 Isolated perfused heart rat; Cardiac troponin I;
Hypoxia/reoxygenation; Immunoassay; _ Is-
chemia/reperfusion 283, 43
Glycaemic control; Calcium; Magnesium; Dia-
betes mellitus 283, 119
Magnesium; Calcium; Glycaemic control; Diabetes
Growth factor; aFGF; ELISA; Pericardial fluid; mellitus 283, 119
Coronary artery disease 283, 171
Metabolites; Diltiazem; SPE; HPLC 283, 63
Hemoglobin; Spectrophotometry; Copper(II)-
phthalocyanine complex; Oxidative decomposi- Monoclonal antibodies; Semen specific y-GTP;
tion reaction 283, 129 ABH antigen carrier protein; Sandwich ELISA
283, 183
Homocysteine, Cysteine; Glutathione; Human cell
lines; Oxidative agents; Redox status; Thiol-reac- Munchausen syndrome, Artifact; Calculi; Factiti-
tive agents 283, 21
ous calculi; Infrared spectrophotometry; Urinary
calculi 283, 151
HPLC; Diltiazem; Metabolites; SPE 283, 63
Neonatal screening; Electrospray-tandem mass
Human cell lines; Cysteine; Glutathione; Homo-
spectrometry; Hyperphenylalaninemia; Phenylal-
cysteine; Oxidative agents; Redox status; Thiol- anine; Tyrosine 283, 15
reactive agents 283, 21
Organic acidemias; Gas chromatography /tandem
Hyperphenylalaninemia: Electrospray-tandem
mass spectrometry; Ion trap GC/MS; Screening
mass spectrometry; Neonatal screening; Phenyl-
283, 77
alanine; Tyrosine 283, 15
Orotic acid; Orotic aciduria; Uracil; Uracil phos-
Hypertension; Sodium/hydrogen exchanger;
phoribosyltransferase 283, 201
Platelets; Acid excretion 283, 105
Hypoxia/reoxygenation; Cardiac troponin I; Im- Orotic aciduria; Orotic acid; Uracil; Uracil phos-
munoassay; Ischemia/reperfusion; Isolated per- phoribosyltransferase 283, 201
fused heart rat 283, 43
Oxidative agents; Cysteine; Glutathione; Homo-
Immunoassay; Cardiac troponin I; Hypoxia/reox- cysteine; Human cell lines; Redox status; Thiol-
ygenation; Ischemia/reperfusion; Isolated per- reactive agents 283, 21
fused heart rat 283, 43
Oxidative decomposition reaction; Spectropho-
Immunoassays; Digoxin; Digibind”; Fab frag- tometry; Hemoglobin; Copper(II)—phthalocyan-
ments 283, 159 ine complex 283, 129
Subject index vol. 283 (1999) 209
Pericardial fluid; aFGF; ELISA; Growth factor; Sodium/hydrogen exchanger; Hypertension;
Coronary artery disease 283, 171 Platelets; Acid excretion 283, 105
Phenylalanine, Electrospray-tandem mass spec- SPE; Diltiazem; Metabolites; HPLC 283, 63
trometry; Hyperphenylalaninemia; Neonatal
screening; Tyrosine 283, 15 Spectrophotometry; Hemoglobin; Copper(II)-
phthalocyanine complex; Oxidative decomposi-
Platelets, Hypertension; Sodium/hydrogen ex- tion reaction 283, 129
changer; Acid excretion 283, 105
Spent CAPD fluid; Aluminium; Copper; Iron;
Point mutation; Butyrylcholinesterase; Three-di- ETAAS 283, 139
mensional structure and atypical gene 283, 33
Thiol-reactive agents; Cysteine; Glutathione;
Presenilin 2; Alzheimer disease; RFLP 283, 57 Homocysteine; Human cell lines; Oxidative
agents; Redox status 283, 21
Redox status; Cysteine; Glutathione; Homocy-
steine; Human cell lines; Oxidative agents; Three-dimensional structure and atypical gene:
Thiol-reactive agents 283, 21 Butyrylcholinesterase; Point mutation 283, 33
RFLP; Alzheimer disease; Presenilin 2 283, 57 Tyrosine; Electrospray-tandem mass spectrometry;
Hyperphenylalaninemia; Neonatal screening;
Sandwich ELISA; Semen specific y-GTP; ABH Phenylalanine 283, 15
antigen carrier protein; Monoclonal antibodies
283, 183 Uracil; Orotic aciduria; Orotic acid; Uracil phos-
phoribosyltransferase 283, 201
Screening; Gas chromatography/tandem mass
spectrometry; lon trap GC/MS; Organic Uracil phosphoribosyltransferase; Orotic acid-
acidemias 283, 77 uria; Orotic acid; Uracil 283, 201
Semen specific y-GTP; ABH antigen carrier pro- Urinary calculi; Artifact; Calculi; Factitious cal-
tein; Monoclonal antibodies; Sandwich ELISA culi; Infrared spectrophotometry; Munchausen
283, 183 syndrome 283, 151
